Latest News and Press Releases
Want to stay updated on the latest news?
-
MAYFIELD VILLAGE, OHIO, March 09, 2026 (GLOBE NEWSWIRE) -- On March 6, 2026, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared a $0.10 per common share dividend, payable...
-
COLLEGEVILLE, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of Linden Ridge, a boutique...
-
SAXONBURG, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR) (“Coherent,” “We,” or the “Company”), a global leader in photonics, today announced it will join the S&P 500 index,...
-
Coherent Launches 700mW Uncooled Micro-Pump Lasers for Improving Efficiency of Scale-Across Networks
New single- and dual-chip uncooled 980nm micro-pump lasers delivering up to 700mW per fiber output
-
Company completes transformation into a triple-engine AI education group preparing the World for the future of work: Genius School, Genius Academy and Genius Resorts SINGAPORE, March 09, 2026 ...
-
Viridien Société anonyme au capital de 7 187 279 eurosSiège social : 27 avenue Carnot, 91300 Massy, France969 202 241 R.C.S. Evry Informations relatives au nombre total de droits de vote et...
-
Viridien A French société anonymewith a share capital of € 7,187,279Registered office: 27 avenue Carnot, 91300 Massy, FranceEvry Trade and Companies Register 969 202 241 Information on the total...
-
TEL AVIV, March 09, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...
-
EventHorizonIQ, available now at https://eventhorizoniq.com/pricing, provides investors and risk professionals with institutional-grade cross-asset regime intelligence Subscription launch represents...
-
Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
DURHAM, N.C., March 09, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet...